The iShares Core MSCI EAFE ETF holds more than 2,600 stocks from over 16 countries.
This international equity fund has underperformed the S&P 500 for the past five years.
But it ranks among the best international ETFs for diversification, low fees, and dividend yield.
Investors seem to be showing more interest in buying stocks beyond the U.S. market. This doesn't mean that the "U.S. exceptionalism" trend is over, but it does mean that there could be good opportunities for investors who diversify into international stocks.
One of the best international exchange-traded funds (ETFs) is the iShares Core MSCI EAFE ETF (NYSEMKT: IEFA). It offers a diversified mix of stocks from more than 16 countries, with top holdings from Japan (25.2% of the fund), the United Kingdom (13.97%), France (8.9%), Switzerland (8.6%) and Germany (8.2%).
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
This fund has slightly underperformed the S&P 500 index year to date, but it has an intriguing mix of holdings in its portfolio that could be worth a look for globally minded investors. Let's see why the iShares Core MSCI EAFE ranks among the best global stock ETFs.
Image source: Getty Images.
The iShares Core MSCI EAFE ETF offers exposure to 2,632 international stocks. This fund owns large-cap, mid-cap, and small-cap stocks with a focus on developed markets beyond Canada and the U.S. "Developed markets" means this ETF invests in stocks based in countries known for political stability, financial regulations, and prosperous economies -- and hopefully, those countries' companies will deliver good returns for shareholders.
The iShares ETF's top five stock holdings (as of May 29) are semiconductor company ASML Holding (2.46% of the fund), international financial services giant HSBC Holdings (1.26%), and multinational pharmaceutical companies Roche (1.16%), AstraZeneca (1.1%), and Novartis (1.08%).
The fund has earned annualized returns (as of April 30) of 8.67% for the past five years, 15.66% for the past three years, and 26.02% in the past year. It has paid an impressive trailing-12-month dividend yield of 3.30%. And it's a low-cost index fund with an expense ratio of only 0.07%.
Unfortunately, this international fund has underperformed the U.S. S&P 500 for the past five years.
Some U.S. investors might hesitate to buy stocks in places like Europe and Japan that have tended to have slower-growing economies than America for the past several years. Why not just keep your money in the U.S. and keep buying artificial intelligence (AI) stocks?
But past performance is no guarantee of future results. In case the U.S. stock market goes into a downturn, especially if U.S. tech stocks tumble from their current high valuations, owning international stocks could help your portfolio stay diversified. International stocks can be a counterweight to U.S. stocks during times of volatility.
The iShares Core MSCI EAFE ETF ranks as one of the best international ETFs because of its low fees, broadly diversified holdings, and high dividends. It could be worth adding to your portfolio.
Before you buy stock in iShares Trust - iShares Core Msci Eafe ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Core Msci Eafe ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $439,632!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,316,532!*
Now, it’s worth noting Stock Advisor’s total average return is 960% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of June 4, 2026.
HSBC Holdings is an advertising partner of Motley Fool Money. Ben Gran has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML and AstraZeneca Plc. The Motley Fool recommends HSBC Holdings and Roche Holding AG. The Motley Fool has a disclosure policy.